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Abstract—Plasmonic gold nanoparticles show potential for
use in a range of cancer diagnostics and therapeutics, such
as photoacoustic imaging (PAI) and plasmonic photothermal
therapy (PPTT). Generally in PPTT, continuous wave (CW)
lasers are used to destroy cancerous tissue. However, in order to
add a diagnostic component through PAI, a pulsed wave (PW)
laser is needed. If PPTT can be achieved using PW lasers then
combined theranostic applications with the same laser system
is possible. Additionally, AuNRs can be many different sizes
but exhibit equivalent surface plasmon resonances, so the size
may be significant in the efficacy of these modalities. We have
demonstrated the potential for gold nanorods to be used for both
PAI and PPTT. The Au10s displayed the highest photoacoustic
signal amplitude and PPTT efficacy. A PW laser was shown to
induce significant cell death to a lung cancer cell line with a
fluence below the maximum permissible exposure, indicating the
possibility for cancer theranostics with a PW laser.
Index Terms—gold nanoparticles, photoacoustic imaging, pho-
tothermal therapy, pulsed laser, contrast agents
I. INTRODUCTION
Plasmonic gold nanorods (AuNRs) have shown potential
for use in a range of cancer diagnostics and therapeutics, such
as photoacoustic imaging (PAI) and plasmonic photothermal
therapy (PPTT) due to their unique optical properties [1],
[2], tuneable surface plasmon resonances (SPRs) [3], relative
biocompatibility [4], and functionalisation prospects [5]. The
capability to synthesise them in large quantities with highly
reproducible and consistent properties is an essential trait
for successful clinical translation [6]. When used as contrast
agents for PAI, they can enhance the optical absorption con-
trast ratio between the surrounding tissues and the region
of interest. To achieve a photoacoustic (PA) response from
AuNRs, the stress confinement condition must be satisfied,
signifying that a pulsed-wave (PW) laser must be used.
AuNRs can also be used for PPTT, whereby they act as
therapeutic agents by converting the absorbed laser-light into
heat and destroying the target tissue [7]. Conventionally, con-
tinuous wave (CW) lasers are used as the optical source, since
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this type of laser system induces hyperthermia in the target
region by generating bulk heating in the tissue surrounding
the AuNRs [8].
A current limitation to these techniques is that they require
the use of different laser types to achieve the desired results,
and combined diagnostic and therapeutic approaches are re-
stricted. If the same laser system could be used for both PAI
and PPTT then combined ‘theranostic’ applications would be
possible, and since CW lasers cannot be used to generate a
PA effect, it would require the use of a PW laser.
The combination of these two modalities could be particu-
larly useful for application in lung cancer. An existing diag-
nostic technique called ‘Endobronchial Ultrasound’ (EBUS)
is an existing diagnostic technique that enables the staging of
lung cancers via needle-biopsy [9]. A bronchoscope with an
ultrasound transducer located on the end is passed through
the mouth and into the lung, and a channel that runs the
length of the bronchoscope allows various diagnostic tools
to be passed through it and provide safe access to a lung
tumour from close proximity [10]. It is conceivable that if a
laser fibre was incorporated into the bronchoscope, instead of
the diagnostic tools, then a photoacoustic-theranostic approach
may be possible by facilitating the illumination of a tumour
from within the lung.
In the presented study, we consider four different sized
AuNRs with similar aspect ratios and SPRs for application
in both PAI and PPTT. The aim is to provide the essential
groundwork for the successful translation of AuNRs from
diagnostics through to therapy by focussing on the use of PW
lasers for a combined theranostic approach.
II. METHODS
A. Gold nanorods
Four different sized citrate-capped AuNRs with similar
aspect ratios and SPRs were bought (A12, Nanopartz, USA)
and their size distributions (Table I) and SPRs were confirmed
via transmission electron microscopy (TEM) (Fig. 1) and spec-
trophotometry. These particular AuNRs were purchased due
TABLE I
DETAILS OF THE AUNRS CONSIDERED IN THIS STUDY AS MEASURED BY
TEM AND SPECTROPHOTOMETRY
Name Dimensions (w × l) [nm] Aspect ratio SPR [nm]
Au10 9.9± 1.1× 39.7± 5.4 3.98± 0.51 811± 2
Au25 23.2± 2.6× 85.6± 9.8 3.73± 0.63 803± 2
Au40 39.8± 4.1× 122.5± 13.8 3.10± 0.35 802± 2
Au50 42.2± 4.6× 142.0± 17.0 3.38± 0.41 841± 2
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Fig. 1. Transmission electron microscope images of the Au10s, Au25s, Au40s
and Au50s before (top row) and after (bottom row) pulsed laser irradiation
(20 pulses, fluence = 20mJ cm−2)
to their highly reproducible properties and size distributions
as ‘off-the-shelf’ AuNRs. The AuNRs were named according
to their certified latitudinal widths: Au10 = 10 nm, Au25 =
25 nm, Au40 = 40 nm, Au50 = 50 nm.
B. Photoacoustic response
The PA response of four different sized AuNRs was mea-
sured using a pre-clinical multi-spectral optoacoustic tomo-
graphic (MSOT) system [11]. The AuNRs were made up
to a concentration of 20 µgml−1 before being sealed inside
plastic straws. The straws containing AuNRs were placed
into a typical turbid, agar-phantom [12] along with a straw
containing water to act as a baseline. A multispectral scan
was performed (680 nm to 980 nm) at six different positions
to obtain an average, and the PA amplitude was calculated at
the peak SPR of each sample.
The AuNRs were also imaged in a tissue-mimicking phan-
tom using an Ultrasound Array Research Platform (UARP) II.
A typical turbid agar phantom was made based on the work
by Rickey et. al. [12]. A small portion of the agar mixture was
combined with Au10 AuNRs at a concentration of 20 µgml−1,
set into a cylindrical shape and placed into a rectangular plastic
container at a depth of 3mm from the edge of the container.
The rest of the agar mixture was then carefully poured into the
same plastic container and left to set around the AuNR-agar
inclusion.
A 128-element linear array transducer (L11-4, Verasonics
Inc., WA, USA) with a central frequency = 7.55MHz and
−6 dB bandwidth of 90.8% was used in conjunction with the
UARP II to image the phantom both actively (plane wave,
9 compounding angles) and passively (PA signal, 100 aver-
ages). A tuneable pulsed laser system (Surelite™OPO Plus,
Continuum®, USA) was used to generate the PA signal from
the AuNRs (pulse width = 7 ns, pulse repetition frequency =
10Hz, spot size = 5mm, laser fluence = 19± 2mJ cm−2 at
the surface of the phantom)
C. Photothermal therapy
A non-small cell lung epithelial carcinoma cell line (A549,
ATCC, UK) was cultured in DMEM (Dulbecco’s Modified
Eagle Medium) media supplemented with 10% FBS (Fetal
Bovine Serum), and once confluent, used to seed a 96-well
plate with approximately 1× 103 cells per well. Following
24 h incubation, the media in all the wells were either re-
plenished with fresh media or replaced with a media-AuNR
solution at a AuNR concentration of 20 µgml−1. The 96-
well plate was then incubated for a further 24 h, to facilitate
the uptake of AuNRs by the lung cancer cells, before being
exposed to laser irradiation.
For comparison, two laser systems were used to perform
PPTT on the A549 cells. A CW diode laser (B4, Sheaumann)
operating at 0.5W (spot size = 8mm) and a tuneable pulsed
laser system (the same used in the PA study) with a laser
pulse fluence of 25±1mJ cm−2. Both of the laser fibres were
mounted to a 3-axis motorised stage and scanned across the
96-well plate. Each well was irradiated for 5min from above
the plate, while an infrared (IR) thermal imaging camera (ther-
moIMAGER TIM 640, Micro-epsilon-Messtechnik GmbH &
Co KG, Germany) recorded a frame every second for the
duration of the exposure. Due to the limitations of IR cameras,
the measurements represent the temperature of the bottom of
the plastic 96-well plate.
This method was repeated for a 96-well plate that contained
only cells (no AuNRs) as well as several plates where the
AuNR-media solution in each well was replaced with fresh
media immediately before laser irradiation to reduce any free-
floating AuNRs.
III. RESULTS AND DISCUSSION
The results from the MSOT system (Fig. 2a) show that the
smallest of the AuNRs (Au10s) produced the strongest PA
signal, with an amplitude of more than three times that of the
Au25s and Au40s. This suggests that, at equivalent total mass
across different sized AuNRs, smaller AuNRs (< 25 nm) are
the most effective PA-converters. Since the Au10s produced
the strongest PA signals, a tissue-mimicking phantom was
made with an inclusion of Au10s at a concentration of
20 µgml−1. Fig. 2b shows the reconstructed B-mode image
of the phantom with the PA image of the inclusion overlaid.
The bright spot seen at a depth of approximately 17mm is a
result of the high-intensity laser pulse hitting the back of the
phantom (as the laser was at a slight angle to accommodate the
ultrasound probe) and generating a strong PA signal. However,
at increased depths the AuNR inclusion is visible. At a depth
of 3 − 8mm, the phantom containing Au10s approximately
mimics typical depths relating to endobronchial ultrasound
(a)
(b)
Fig. 2. (a) The photoacoustic amplitude of four different sized AuNRs with
certified lateral widths of 10nm (Au10), 25nm (Au25), 40nm (Au40), and
50nm (Au50), measured with a MSOT system. (b) A B-mode plane-wave
image (9 compounding angles) of a tissue-mimicking agar phantom with an
overlaid photoacoustic image generated by a 5mm diameter inclusion of
Au10 AuNRs (concentration 20 µgml−1) at a depth of 3mm below the
surface and a laser fluence = 15± 2mJ cm−2 at the surface. The PA signal
is referenced to the maximum of the B-mode image (dB).
of lung tumours. The non-uniform signal from the Au10s
is likely due to an inhomogeneous distribution of AuNRs
throughout the inclusion, as a direct result of making the
inclusion. The results demonstrate the ability for AuNRs to
be used as contrast agents for PAI of lung tumours.
The PPTT efficacy of the four different AuNR sizes was
determined under both PW and CW laser irradiation. The PW
laser fluence was 25 ± 1mJ cm−2 (below 31mJ cm−2, the
maximum permissible exposure of laser irradiation to skin
[13]) and the CW power output was 0.5W. Fig. 3a shows the
cell viability of the A549 cells under various parameters and
with the free-floating AuNRs remaining. When the cells were
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Fig. 3. Lung cancer cell viability (A549) after PW laser exposure only (green),
CW laser exposure only (orange), incubation with AuNRs without laser
exposure (beige), incubation with AuNRs combined with PW laser exposure
(blue), and incubation with AuNRs combined with CW laser exposure (red).
(a) AuNR-media was not replaced before laser irradiation (i.e. free-floating
AuNRs remained), and (b) free-floating AuNRs were removed before laser
irradiation by replacing the AuNR-media solution with fresh media. AuNR
concentration = 20 µgml−1, PW laser fluence = 25± 1mJ cm−2 and CW
power = 0.5W for all data points.
illuminated by the PW or CW laser only, without incubation
with AuNRs, no cell death was observed. However, once the
different sized AuNRs were incubated with the cells for 24 h
to facilitate uptake of the AuNRs by the cells, significant cell
death was observed for all AuNR sizes under both PW and
CW laser irradiation. The data indicate the importance of both
AuNRs and laser irradiation to induce cell death. The CW laser
showed the highest cell toxicity across all four AuNR sizes
compared with the PW laser, however this was likely due to
the bulk heating effect observed as a result of the free-floating
AuNRs remaining in each of the wells. Fig. 4a shows a single
frame taken with the IR camera displaying the temperature
difference between the well under PW (green circle) and CW
(blue circle) laser irradiation. Fig. 4b & 4c show an example
of the temperature profile of the cells under CW and PW
laser irradiation, and the temperature of the wells under CW
exposure can be seen to have increased several degrees.
The PPTT study was repeated with the free-floating AuNRs
removed from each well by replacing the AuNR-media solu-
tion with fresh media, leaving the AuNRs that were either
internalised by the cells or stuck to the surface of the cells
(Fig. 3b). Significant cell death (< 60%) was also observed
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Fig. 4. (a) Infrared thermal image of the bottom of a 96-well plate containing
A549 cells and Au40 AuNRs during laser irradiation with both a PW
(green circle) and CW (blue circle) laser, and the temperature profile of
the cells under (b) CW laser irradiation with free-floating AuNRs, (c) PW
laser irradiation with free-floating AuNRs, (d) CW laser irradiation with
free-floating AuNRs removed and (e) PW laser irradiation with free-floating
AuNRs removed. Due to the limitations of infrared cameras, the measured
temperature is that of the bottom of the 96-well plate.
for the cells incubated with all AuNR sizes and exposed to
laser irradiation. However, the cellular toxicity induced by
both the PW and CW lasers was comparable in this case,
indicating that the removal of free-floating AuNRs reduced
the PPTT efficacy of the CW laser. Fig. 4d & 4e show an
example of the temperature profile of the cells under CW and
PW laser irradiation, and the temperature of the wells under
CW displayed a reduced temperature increase compared with
that of the free-floating AuNRs. The data suggest that PW are
able to perform PPTT of lung cancer at fluence levels below
the safe exposure limit.
The photostability of the four different AuNRs was mea-
sured after 20 laser pulses with a fluence of 20mJ cm−2. Fig.
1 shows TEM images of each AuNR size before (top row) and
after laser irradiation. The images clearly show that almost
the entire population of Au25s, Au40s and Au50s had melted
into complete spheres, whereas the Au10s appeared to resist
complete melting and still retain a significant portion of rod-
shaped particles. This indicates the increased photostability of
the Au10s and potentially smaller AuNRs in general.
IV. CONCLUSIONS
We have shown that AuNRs have the potential to be used
for both diagnostic and therapeutic modalities such as PAI
and PPTT. The use of PW lasers for PAI is evident, and
we have demonstrated that PPTT is also possible with a
PW laser at laser fluence levels below the MPE for skin.
Significant cell death was observed for all AuNR sizes when
combined with both PW and CW laser irradiation, however
laser irradiation alone was not sufficient. The AuNR sizes had
an effect on overall PPTT efficacy and the smallest AuNRs
(Au10s) induced the highest cell-death.
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